Clinical Trial Detail

NCT ID NCT01871805
Title A Study of CH5424802/RO5424802 in Patients With ALK-Rearranged Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Hoffmann-La Roche
Indications

non-small cell lung carcinoma

Therapies

Alectinib

Age Groups: adult

Additional content available in CKB BOOST